Ordinary Rebalance | Solactive Global Healthcare 20 Index | Effective Date 23rd January 2023
In the ordinary rebalance, the following index composition will be implemented effective open 23.01.2023:
ABBOTT LABORATORIES |
ABBVIE INC |
AMGEN INC |
ASTRAZENECA PLC |
BRISTOL-MYERS SQUIBB CO |
CSL LTD ORD |
DANAHER CORP |
ELI LILLY & CO |
GILEAD SCIENCES INC |
JOHNSON & JOHNSON |
MEDTRONIC PLC |
MERCK & CO. INC. |
NOVARTIS AG |
NOVO NORDISK A/S |
PFIZER INC |
ROCHE HOLDING AG |
SANOFI SA |
SIEMENS AG |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |